Faculty

Katheryn Alexandra Quilico Cousins-Gershenson, PhD

faculty photo
Research Assistant Professor of Neurology
Department: Neurology
Graduate Group Affiliations

Contact information
Richards Medical Building, Suite 600B
3700 Hamilton Walk
Philadelphia, PA 19104
Education:
BA ( Biological Sciences)
University of Chicago, 2007.
PhD (Neuroscience)
Brandeis University, 2015.
Permanent link
 

Description of Research Expertise

Biofluid markers of neuropathology

Selected Publications

Elser, Cousins, Gee, Boyle, Massimo, Brown, Shaw, Lee, Weisskopf, McMillan, & Wolk: Long-term air pollution exposure and Alzheimer disease biofluid biomarkers. National Alzheimer’s Coordinating Center (NACC) Spring ADRC Meeting, Atlanta, GA May 2026.

Rhodes, Cousins, Philips, Lee, Wolk & McMillan: Progressive amnestic syndrome in the absence of AD biomarkers and TDP-43 pathology: Primary age-related tauopathy as a clinical mimic of limbic-predominant age-related TDP-43 encephalopathy. Invited Talk, National Alzheimer’s Coordinating Center (NACC)/ADRC LATE webinar series April 2026.

Honey, Thijssen, Hok-A-Hin, Cousins, Weijden, Veld, Stoops, de Boer, Duits, Houwer, Morrema, Alcolea, Illán-Gala, Fortea, Lleó, Boxer, Irwin, Lee, Shaw, McMillan, Wolk, Hoozemans, van der Flier, van der Ende, Seelaar, Verberk, Gan, Pijnenburg, Teunissen: An Acetylated Tau-174 CSF Biomarker Discriminates Between TDP-43 and Tau Pathology in Patients with Frontotemporal Degeneration. Invited Talk: Restoring Neural Resilience in ALS and Alzheimer’s Disease Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.

Cousins, Boyle, Morse, Verma, Brown, O’Brien, Serper, Dehghani, Penn Medicine BioBank, McMillan, Lee, Shaw, & Wolk: Electronic health records to test multimorbidity influences to plasma biomarker interpretation for Alzheimer’s disease. Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.

Simrén, Rönnholm, Weiner, Pola, Benedet, Shaw, Wolk, Weintraub, Lee, McMillan, Blennow, Irwin, Zetterberg*, Gobom*, & Cousins*: Cerebrospinal fluid proteomic profiling in frontotemporal lobar degeneration, Alzheimer’s disease and Lewy body disease. Invited Talk: Biomarker Signatures in Preclinical AD and Neurodegenerative Diseases Alzheimer's Disease Parkinson’s Disease (AD/PD) March 2026.

Brown CA, Mundada NS, Cousins KAQ, Sadeghpour N, Lyu X, McGrew E, Korecka M, Chen-Plotkin A, Xie L, Wisse LEM, Detre JA, McMillan CT, Lee EB, Nasrallah IM, Das SR, Mechanic-Hamilton D, Yushkevich PA, Shaw LM, Wolk DA; Alzheimer’s Disease Neuroimaging Initiative.: Evaluation of Copathology and Clinical Trajectories in Individuals With Tau-Clinical Mismatch. JAMA Neurol 83: 126-136, Feb 2026.

Cousins KAQ, Boyle R, Morse C, Verma A, Brown CA, O'Brien KS, Serper M, Dehghani N; Penn Medicine BioBank; McMillan CT, Lee EB, Shaw LM, Wolk DA.: Electronic Health Records to Test Multimorbidity Influences to Plasma Biomarker Interpretation for Alzheimer's Disease. Ann Neurol Dec 2025.

Kwiecinski, Dratch, Andrews, Dengel, Kamel, Legaspi, McMillan, Massimo, Cousins, & Irwin : Evaluating the Impact of Predictive Genetic Counseling in Frontotemporal Dementia: A Pilot Analysis. National Society of Genetic Counselors (NSGC) 44th Annual Conference Nov 2025.

Ohm, Capp, Sabitini, Cousins, Phillips, Rascovsky, Wolk, Lee, McMillan, & Irwin : Selectively vulnerable myeloarchitecture in behavioral variant frontotemporal dementia. Society for Neuroscience (SfN) Nov 2025.

Luna, Cousins, Emrani, Luk, Lee, Lee, Weintraub, Xie, Chen-Plotkin, Bennett, & Irwin: Lewy Pathology correlates with neuroinflammation in the hippocampus of Synucleinopathy patients in a subregion specific manner. International Congress of Parkinson’s Disease and Movement Disorders Oct 2025.

back to top
Last updated: 05/19/2026
The Trustees of the University of Pennsylvania